Key features and details
- Mouse monoclonal [UW40] to GRAP2 (PE)
- Suitable for: Flow Cyt
- Reacts with: Human
- Conjugation: PE. Ex: 488nm, Em: 575nm
- Isotype: IgG2a
Product nameAnti-GRAP2 antibody [UW40] (PE)
See all GRAP2 primary antibodies
DescriptionMouse monoclonal [UW40] to GRAP2 (PE)
ConjugationPE. Ex: 488nm, Em: 575nm
Tested applicationsSuitable for: Flow Cytmore details
Species reactivityReacts with: Human
Fusion protein corresponding to Human GRAP2. GST-fusion human GRAP2/GADS protein.
Database link: O75791
- Flow Cyt: Human peripheral whole blood.
Storage instructionsShipped at 4°C. Store at +4°C. Store In the Dark.
Storage bufferPreservative: 0.0975% Sodium azide
Constituent: 99.9% PBS
Concentration information loading...
Purification notesThe purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. The conjugate is purified by size-exclusion chromatography.
Our Abpromise guarantee covers the use of ab278056 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Flow Cyt||Use a concentration of 1.7 µg/ml.|
FunctionInteracts with SLP-76 to regulate NF-AT activation. Binds to tyrosine-phosphorylated shc.
Sequence similaritiesBelongs to the GRB2/sem-5/DRK family.
Contains 1 SH2 domain.
Contains 2 SH3 domains.
- Information by UniProt
- Adapter protein GRID antibody
- GADS antibody
- GADS protein antibody
Flow cytometric analysis of human peripheral whole blood labeling GRAP2 using ab278056 at 1.7 μg/ml. Intracellular staining.
Flow cytometric analysis of human peripheral whole blood monocytes labeling GRAP2 using ab278056 at 1.7 μg/ml (Red) as compared to a Mouse IgG2a-PE isotype control (Black). The secondary antibody is a Goat Anti-Mouse APC conjugate. Intracellular staining.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab278056 has not yet been referenced specifically in any publications.